Reaction
Hepatitis Viral reporting signals
As of the last recalculation, Hepatitis Viral appears in 791 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is OLANZAPINE PAMOATE (PRR 59.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Olanzapine Pamoate | 83 | 59.5 | 59.6 |
| Brentuximab Vedotin | 17 | 44.6 | 44.7 |
| Esomeprazole Magnesium Capsule, Delayed Release | 15 | 27.7 | 27.7 |
| Esomeprazole Magnesium Delayed Release Capsules | 15 | 27.7 | 27.7 |
| Bendamustine Hcl | 16 | 27.7 | 27.7 |
| Esomeprazole Magnesium Dihydrate | 15 | 27.6 | 27.6 |
| Valganciclovir | 18 | 25.7 | 25.7 |
| Valganciclovir Hydrochloride | 18 | 25.7 | 25.7 |
| Olanzapine | 93 | 25.7 | 25.7 |
| Methocarbamol | 20 | 23.8 | 23.8 |
| Acetylcysteine | 8 | 22.6 | 22.6 |
| Bendamustine Hydrochloride | 9 | 20.0 | 20.0 |
| Valganciclovir Hydrochloride Powder, | 9 | 19.6 | 19.6 |
| Fludarabine Phosphate | 23 | 15.8 | 15.8 |
| Lisdexamfetamine Dimesylate | 19 | 15.5 | 15.5 |
| Vemurafenib | 5 | 11.0 | 11.0 |
| Carfilzomib | 11 | 10.4 | 10.4 |
| Cariprazine | 3 | 8.5 | 8.5 |
| Obinutuzumab | 5 | 8.0 | 8.0 |